Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,268,585,398
-
Number of holders
-
2319
-
Total 13F shares, excl. options
-
1,029,470,276
-
Shares change
-
+7,211,973
-
Total reported value, excl. options
-
$106,176,980,983
-
Value change
-
+$782,593,506
-
Put/Call ratio
-
1.03%
-
Number of buys
-
1,065
-
Number of sells
-
-905
-
Price
-
$103.16
Significant Holders of CVS HEALTH Corp - Common Stock (CVS) as of Q4 2021
2,479 filings reported holding CVS - CVS HEALTH Corp - Common Stock as of Q4 2021.
CVS HEALTH Corp - Common Stock (CVS) has 2,319 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,029,470,276 shares
of 1,268,585,398 outstanding shares and own 81.15% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (109,236,922 shares), BlackRock Inc. (93,556,501 shares), STATE STREET CORP (56,810,314 shares), Capital World Investors (50,102,110 shares), Capital International Investors (27,821,477 shares), MORGAN STANLEY (24,281,050 shares), GEODE CAPITAL MANAGEMENT, LLC (22,099,200 shares), JPMORGAN CHASE & CO (19,331,778 shares), Invesco Ltd. (17,691,791 shares), and BANK OF AMERICA CORP /DE/ (17,308,556 shares).
This table shows the top 2319 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.